Cargando…
CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
BACKGROUND: Lung adenocarcinoma (ACA) is the most common subtype of non-small-cell lung cancer. About 70%–80% patients are diagnosed at an advanced stage; therefore, the survival rate is poor. It is urgent to discover accurate markers that can differentiate the late stages of lung ACA from the early...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
PeerJ Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547618/ https://www.ncbi.nlm.nih.gov/pubmed/33083148 http://dx.doi.org/10.7717/peerj.10126 |